BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27999236)

  • 1. CD8+ T Lymphocyte Subsets in Bladder Tumor Draining Lymph Nodes.
    Faghih Z; Shobeiri SS; Ariafar A; Sarkarian M; Zeighami S; Nazari N; Abbasi-Sarvak S; Erfani N
    Iran J Immunol; 2016 Dec; 13(4):237-248. PubMed ID: 27999236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17 and IL-4 producing CD8+ T cells in tumor draining lymph nodes of breast cancer patients: positive association with tumor progression.
    Faghih Z; Rezaeifard S; Safaei A; Ghaderi A; Erfani N
    Iran J Immunol; 2013 Dec; 10(4):193-204. PubMed ID: 24375061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma.
    Andrade MC; Ferreira SB; Gonçalves LC; De-Paula AM; de Faria ES; Teixeira-Carvalho A; Martins-Filho OA
    Hum Immunol; 2013 Dec; 74(12):1563-74. PubMed ID: 23994583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes.
    Faghih Z; Erfani N; Haghshenas MR; Safaei A; Talei AR; Ghaderi A
    Immunol Lett; 2014; 158(1-2):57-65. PubMed ID: 24326038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-17/IFN-γ double producing CD8+ T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12.
    Tajima M; Wakita D; Satoh T; Kitamura H; Nishimura T
    Int Immunol; 2011 Dec; 23(12):751-9. PubMed ID: 22039016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8-positive memory T cells in tumor-draining lymph nodes of patients with breast cancer.
    Vahidi Y; Bagheri M; Ghaderi A; Faghih Z
    BMC Cancer; 2020 Mar; 20(1):257. PubMed ID: 32228503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lymphocyte activation markers in patients with ovarian cancer].
    Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
    Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine- and Ig-producing T cells in mucosal effector tissues: analysis of IL-5- and IFN-gamma-producing T cells, T cell receptor expression, and IgA plasma cells from mouse salivary gland-associated tissues.
    Mega J; McGhee JR; Kiyono H
    J Immunol; 1992 Apr; 148(7):2030-9. PubMed ID: 1545116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tumor infiltrating regulatory T cells in human breast cancer and associated draining lymph nodes: an in-situ analysis].
    Wang HY; Shi QF; Sun Y; He JJ; Wang YL
    Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):95-100. PubMed ID: 23710915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood T lymphocyte subsets in children with congenital asplenia.
    Motkowski R; Michalkiewicz J; Mikoluc B; Smolka-Afifi D; Pietrucha B; Kubiszewska I; Piotrowska-Jastrzebska J; Bernatowska E
    Hum Immunol; 2012 Nov; 73(11):1091-7. PubMed ID: 22902394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memory CD4
    Vahidi Y; Faghih Z; Talei AR; Doroudchi M; Ghaderi A
    Cell Oncol (Dordr); 2018 Feb; 41(1):1-11. PubMed ID: 28994018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.
    Liyanage UK; Moore TT; Joo HG; Tanaka Y; Herrmann V; Doherty G; Drebin JA; Strasberg SM; Eberlein TJ; Goedegebuure PS; Linehan DC
    J Immunol; 2002 Sep; 169(5):2756-61. PubMed ID: 12193750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of activation-related molecules on regional lymph node lymphocytes in human lung cancer.
    Takenoyama M; Yasumoto K; Harada M; Matsuzaki G; Ishida T; Sugimachi K; Nomoto K
    Immunobiology; 1996 Jul; 195(2):140-51. PubMed ID: 8877391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of Regulatory T-Cells and Other Phenotypes of T-Cells in Tumors and Regional Lymph Nodes of Colorectal Cancer Patients.
    Kazama K; Otake J; Satoyoshi T; Shiozawa M; Sugano N; Sato S; Atsumi Y; Kano K; Murakawa M; Maezawa Y; Hashimoto I; Numata M; Oshima T; Yukawa N; Rino Y; Sasada T; Masuda M
    In Vivo; 2020; 34(2):849-856. PubMed ID: 32111794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM-CSF-producing lymphocytes in tumor-draining lymph nodes of patients with bladder cancer.
    Ariafar A; Zareinejad M; Soltani M; Vahidi Y; Faghih Z
    Eur Cytokine Netw; 2021 Mar; 32(1):1-7. PubMed ID: 34346868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.
    Amel-Kashipaz MR; Huggins ML; Lanyon P; Robins A; Todd I; Powell RJ
    J Autoimmun; 2001 Sep; 17(2):155-63. PubMed ID: 11591124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8(+) Tc1 and Tc2 cells.
    Vinay DS; Kwon BS
    Cell Immunol; 1999 Feb; 192(1):63-71. PubMed ID: 10066348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer.
    Severson JJ; Serracino HS; Mateescu V; Raeburn CD; McIntyre RC; Sams SB; Haugen BR; French JD
    Cancer Immunol Res; 2015 Jun; 3(6):620-30. PubMed ID: 25701326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.